After circulation returns, previously ischemic myocardium is exposed to reperfusion-related injury and oxidative stress. These processes can disrupt cellular function and reduce effective contraction, while the intense catecholamine response may add further myocardial strain. Together, they help explain why cardiac performance can remain impaired during early recovery even after spontaneous circulation has been restored.
Altered calcium handling interferes with the normal excitation-contraction process that allows cardiac muscle to generate force. In post-resuscitation myocardial dysfunction, this disturbance contributes to reduced contractility and impaired pump performance. Recognizing calcium-related dysfunction helps explain why the impairment may be reversible myocardial stunning rather than evidence of permanent structural loss of cardiac function.
The key distinction is the expected reversibility of myocardial stunning after the arrest and resuscitation sequence compared with ongoing dysfunction from persistent cardiac disease. Reduced ejection fraction and low cardiac output can occur in either setting, so clinicians must interpret these findings with the clinical context and hemodynamic assessment. This distinction supports more accurate stabilization and prognostic evaluation.
Assessment should focus on cardiac contractility, ejection fraction, cardiac output, and filling pressures. Echocardiography can characterize impaired ventricular performance, while circulatory monitoring helps evaluate the hemodynamic consequences for tissue perfusion. Considering these findings together is more informative than relying on a single measurement, because the condition may combine weak contraction with elevated filling pressures.
Fluid management and vasoactive therapy are selected to address the patient’s hemodynamic state after return of spontaneous circulation. Their purpose is to support circulation while clinicians account for reduced contractility, low cardiac output, and potentially elevated filling pressures. Targeted treatment, guided by echocardiography and circulatory monitoring, helps support tissue perfusion during early post-arrest stabilization.
Recognition separates a potentially reversible post-arrest myocardial response from persistent cardiac disease and places abnormal hemodynamic findings in the correct clinical context. This improves interpretation of reduced ejection fraction, low output, and elevated filling pressures during recovery. It also supports targeted stabilization and more informed prognostic evaluation, rather than treating every early cardiac abnormality as permanent dysfunction.